This study just adds to a growing body of evidence that indicates Zocor side effects, especially those associated with higher doses, can be extremely dangerous.
New York, New York (PRWEB) April 13, 2013
Bernstein Liebhard LLP notes that a new study is raising additional concerns about possible Zocor side effects, specifically kidney damage. The study, which was published online on March 19 in the British Medical Journal, found that patients treated with higher doses of statins like Zocor were 34% more likely to be hospitalized for acute kidney injury during the first 120 days of treatment.*
“This study just adds to a growing body of evidence that indicates Zocor side effects, especially those associated with higher doses, can be extremely dangerous. We have heard from a number of Zocor patients who have allegedly experienced serious complications, including rhadbomyolysis, a devastating muscle disorder that can lead to kidney damage,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is currently offering free legal evaluations to victims of Zocor side effects.
The British Medical Journal study involved more than 2 million people aged 40 or over taking either high or low doses of the statins Crestor, Lipitor or Zocor. According to the study authors, risk for acute kidney injury remained elevated for two years after the start of treatment. Pre-existing kidney disease was not found to increase the risk for acute kidney problems independent of statin use.
Zocor Muscle Injury Side Effects
According to Bloomberg.com, Zocor, known generically as simvastatin, ranks as one of the world’s best-selling drugs.** However, the medication has been linked to a number of serious Zocor side effects, including muscle injury, myopathy and rhadbomyolysis. In March 2010, the U.S. Food and Drug Administration (FDA) advised that the higher 80 mg dose of Zocor could be associated with muscle injuries. At the time, the agency also cautioned that the risk of Zocor muscle injuries increases for patients who take the drug in conjunction with other blood pressure medications.***
On June 8, 2011, the FDA added new warnings to Zocor’s labeling, and advised physicians not to prescribe high doses of Zocor to new patients. According to the FDA, high-dose Zocor prescriptions should be limited to patients who have taken 80 mg doses of Zocor for more than a year and have not experienced side effects. The FDA has cautioned patients to contact their doctor if they experience muscle pain, tenderness or weakness, dark or red colored urine, or unexplained tiredness, as these could be signs of serious Zocor side effects.****
Individuals who experienced Zocor side effects, including muscle injury, myopathy, or rhadbomyolysis may be able to collect compensation for medical expenses, lost wages, pain and suffering, and more. To learn more about filing a Zocor lawsuit, please visit Bernstein Liebhard LLP’s website. For additional information, contact a lawyer at Bernstein Liebhard LLP today at (877) 779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP